Table 1 Comparison of the analyzed clinical and laboratory data in ALS patients stratified by FVC.

From: Venous blood parameters in determination of respiratory impairment in amyotrophic lateral sclerosis

Variable

The retrospective cohort

The prospective cohort

Total

FVC: normal

(Male and FVC < 3.062) or (female and FVC < 2.266)

P

Total

FVC: normal

(Male and FVC < 3.062) or (female and FVC < 2.266)

P

Gender

319

187

132

 

97

58

39

 

 Male

230

138 (73.80%)

92 (69.70%)

0.421

59

33 (56.90%)

26 (66.67%)

0.334

 Female

89

49 (26.20%)

40 (30.30%)

 

38

25 (43.10%)

13 (33.33%)

 

Age (year)

319

51.75 ± 9.72

59.71 ± 10.83

< 0.001

97

52.53 ± 11.00

61.64 ± 10.46

< 0.001

Onset age (year)

319

50.62 ± 9.77

58.35 ± 11.19

< 0.001

97

51.67 ± 10.95

60.44 ± 10.52

< 0.001

Hypertension

315

184

131

 

97

58

39

 

SBP (mmHg)

315

130.00 (23.00)

130.00 (25.00)

0.387

97

125.00 (25.00)

132.00 (35.00)

0.319

DBP (mmHg)

315

88.00 (17.00)

84.00 (19.00)

0.022

97

81.43 ± 12.42

86.21 ± 14.02

0.486

Weight (kg)

319

63.00 (14.00)

55.00 (10.75)

< 0.001

97

60.19 ± 8.96

55.00 ± 8.87

0.006

Height (m)

319

1.63 ± 0.08

1.58 ± 0.07

< 0.001

97

1.61 ± 0.07

1.59 ± 0.08

0.110

BMI (kg/m2)

319

23.26 ± 3.02

21.81 ± 2.84

< 0.001

97

23.03 ± 2.57

21.79 ± 3.29

0.041

Site of onset

319

187

132

 

97

58

39

 

Limb onset

259

159 (85.03%)

100 (75.76%)

0.092

75

46 (79.31%)

29 (74.36%)

0.568

Bulbar onset

51

23 (12.30%)

28 (21.21%)

 

22

12 (20.69%)

10 (25.64%)

 

Other

9

5 (2.67%)

4 (3.03%)

 

0

0

0

 

Diagnostic level

319

187

132

 

97

58

39

 

Probable

155

94 (50.27%)

61 (46.21%)

0.475

70

44 (75.86%)

26 (66.67%)

0.322

Definite

164

93 (49.73%)

71 (53.79%)

 

27

14 (24.14%)

13 (33.33%)

 

Disease duration (m)

319

11.00 (11.00)

12.00 (17.00)

0.072

97

11.50 (10.00)

12.00 (18.00)

0.205

PLT (109/L)

319

183.00 (80.00)

183.00 (70.75)

0.815

97

168.00 (75.25)

186.00 (65.00)

0.079

WBC (109/L)

319

5.83 (1.97)

5.83 (2.36)

0.412

97

5.31 (1.69)

5.36 (1.83)

0.965

NEUT# (109/L)

319

3.39 (1.60)

3.41 (1.54)

0.826

97

3.21 ± 0.98

3.40 ± 1.14

0.401

LYMPH# (109/L)

319

1.82 (0.58)

1.64 (0.79)

0.007

97

1.60 (0.82)

1.41 (0.84)

0.106

PLR

319

101.72 (51.15)

114.58 (67.12)

0.023

97

95.49 (63.58)

127.45 (84.11)

0.037

NLR

319

1.87 (1.10)

2.05 (1.00)

0.116

97

1.91 (0.95)

2.04 (1.45)

0.131

MONO# (109/L)

319

0.41 (0.18)

0.39 (0.15)

0.595

97

0.38 (0.15)

0.39 (0.18)

0.962

EO# (109/L)

318

0.12 (0.12)

0.11 (0.12)

0.296

97

0.15 (0.16)

0.12 (0.15)

0.306

BASO# (109/L)

318

0.03 (0.02)

0.03 (0.02)

0.834

97

0.02 (0.02)

0.02 (0.01)

0.29

ALB (g/L)

319

42.70 (4.40)

42.20 (4.68)

0.144

97

42.15 (3.88)

41.90 (4.90)

0.991

GLU (mmol/L)

319

4.72 (0.83)

4.94 (0.69)

0.018

97

4.68 (0.70)

4.72 (0.84)

0.659

UREA (mmol/L)

319

5.00 (1.50)

5.30 (2.08)

0.154

97

5.50 (2.03)

5.50 (2.30)

0.664

CREA (µmol/L)

319

62.00 (16.00)

56.00 (19.00)

< 0.001

97

61.00 (19.25)

59.00 (33.00)

0.985

URIC (µmol/L)

319

311.00 (86.00)

303.50 (103.25)

0.449

97

291.00 (101.50)

280.00 (114.00)

0.749

TG (mmol/L)

319

1.33 (1.04)

1.15 (0.68)

0.004

97

1.32 (0.95)

1.12 (0.43)

0.050

CHOL (mmol/L)

319

4.60 ± 0.86

4.66 ± 0.90

0.566

97

4.42 ± 0.83

4.69 ± 1.08

0.165

CK (mmol/L)

319

165.00 (209.00)

170.50 (183.50)

0.984

97

143.00 (137.75)

104.00 (103.00)

0.109

LDL (mmol/L)

319

2.73 ± 0.73

2.69 ± 0.79

0.651

97

2.66 ± 0.69

2.83 ± 0.87

0.276

HDL (mmol/L)

319

1.19 (0.42)

1.34 (0.50)

< 0.001

97

1.21 (0.33)

1.31 (0.39)

0.025

LDL/HDL

319

2.38 (1.07)

2.08 (1.05)

0.001

97

2.19 (0.92)

1.90 (1.19)

0.199

CCI

319

0.00 (0.00)

0.00 (1.00)

0.056

97

0.00 (0.00)

0.00 (0.00)

0.690

  1. SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, PLT platelet count, WBC white blood count, NEUT# neutrophil count, LYMPH# lymphocyte count, PLR the ratio of PLT to LYMPH#, NLR the ration of NEUT# to LYMPH#, MONO# monocyte count, EO# eosinophil count, BASO# basophil count, ALB albumin, GLU glucose, UREA urea, CREA creatinine, URIC uric acid, TG triglyceride, CHOL cholesterol, CK creatine kinase, LDL low-density lipoprotein cholesterol, HDL high-density lipoprotein cholesterol, LDL/HDL the ratio of LDL to HDL, CCI Charlson Comorbidity Index.